











The orexins, also called hypocretins (Sakurai et al. 1998; de
Lecea et al. 1998), are a novel pair of hypothalamic
neuropeptides implicated in the regulation of energy
balance and arousal (see Willie et al. 2001; Sutcliffe & de
Lecea, 2002 for reviews).  Initial excitement about these
peptides derived from the finding that both forms of
orexin (orexin-A and orexin-B) are synthesized exclusively
by neurones located in the lateral hypothalamic area
(LHA) and adjacent perifornical region, areas classically
implicated in the control of mammalian feeding behaviour
(Sakurai et al. 1998; Peyron et al. 1998; Date et al. 1999).
Additionally, it was shown that intracerebroventricular
administration of orexins or injection of these peptides
directly into specific hypothalamic loci produced dose-
dependent increases in food intake in rats (Sakurai et al.
1998; Dube et al. 1999), whereas administration of orexin
antibodies (Yamada et al. 2000) inhibited feeding in fasted
animals.  Moreover, the hypothalamic expression of
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Orexin (hypocretin)-containing projections from lateral hypothalamus (LH) are thought to play an
important role in the regulation of feeding behaviour and energy balance. In rodent studies, central
administration of orexin peptides increases food intake, and orexin neurones in the LH are
activated by hypoglycaemia during fasting. In addition, administration of orexins into the fourth
ventricle or the dorsal motor nucleus of the vagus (DMV) has been shown to stimulate gastric acid
secretion and motility, respectively, via vagal efferent pathways. In this study, whole-cell recordings
were obtained from DMV neurones in rat brainstem slices to investigate the cellular mechanism(s)
by which orexins produce their gastrostimulatory effects.  To determine whether responsiveness to
orexins might be differentially expressed among distinct populations of preganglionic vagal motor
neurones, recordings were made from neurones whose projections to the gastrointestinal tract had
been identified by retrograde labelling following apposition of the fluorescent tracer DiI to the
gastric fundus, corpus or antrum/pylorus, the duodenum or caecum. Additionally, the responses of
neurones to orexins were compared with those produced by oxytocin, which acts within the DMV to
stimulate gastric acid secretion, but inhibits gastric motor function.  Bath application of orexin-A or
orexin-B (30–300 nM) produced a slow depolarization, accompanied by increased firing in 47 of 102
DMV neurones tested, including 70 % (30/43) of those that projected to the gastric fundus or
corpus. In contrast, few DMV neurones that supplied the antrum/pylorus (3/13), duodenum (4/18)
or caecum (1/13) were responsive to these peptides. The depolarizing responses were concentration
dependent and persisted during synaptic isolation of neurones with TTX or Cd2+, indicating they
resulted from activation of postsynaptic orexin receptors. They were also associated with a small
increase in membrane resistance, and in voltage-clamp recordings orexin-A induced an inward
current that reversed near the estimated equilibrium potential for K+, indicating the depolarization
was due in large part to a reduction in K+ conductance. Orexins did not affect synaptically evoked
excitation, but did reduce membrane excitability in a subset of gastric-projecting DMV neurones by
enhancing GABA-mediated synaptic input. Lastly, although many DMV neurones responded to
orexins and oxytocin with excitation, for the most part these peptides modulated excitability of
distinct populations of gastric-projecting vagal motor neurones.  These results indicate that orexins
act preferentially within the DMV to directly excite vagal motor neurones that project to gastric
fundus and corpus. In this way, release of endogenous orexins from descending hypothalamic
projections into the DMV may mediate the increase in gastric acid secretion and motor activity
associated with the cephalic phase of feeding.
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prepro-orexin mRNA is increased by fasting (Sakurai et al.
1998) and after acute hypoglycaemia when food is withheld
(Cai et al. 1999), while conversely down-regulated in
genetically obese ob and db mice (Yamamoto et al. 1999).
These data, together with more recent findings that orexin
neurones show robust activation to hypoglycemic challenge
in fasted rats (Cai et al. 2001), suggest that orexins may be
involved in the acute control of glucostatic feeding in
addition to homeostatic mechanisms that regulate energy
balance.
Orexin immunoreactive axonal fibres are widely distributed
throughout the neuraxis, with the most prominent
projections found in hypothalamic and brainstem nuclei
known to be important in feeding-related behaviours or
maintenance of wakefulness (Peyron et al. 1998; Horvath
et al. 1999a,b). In addition, orexin-containing nerve fibres
and specific receptors for orexins are found in moderate to
high density in many autonomic centres in rat brainstem
and spinal cord, including the dorsal vagal complex
(DVC) in the medulla (Harrison et al. 1999; Krowicki et al.
2002). The DVC consists of the nucleus of the solitary tract
(NTS) and dorsal motor nucleus of the vagus (DMV) that
together form the hub of a central neural network that
provides parasympathetic control over the gastrointestinal
(GI) tract and coordinates digestive functions (Gillis et al.
1989; Powley et al. 1992). The NTS receives various kinds
of visceral information from sensory vagal afferents that
supply diverse regions of the GI tract, and in turn projects
heavily onto preganglionic motor neurones in the DMV
that are the major source of parasympathetic innervation
to the subdiaphragmatic visceral organs (Gillis et al. 1989).
These connections provide the neural substrate for a
variety of vagovagal reflexes involved in the feedback
regulation of GI functions. Moreover, modulation of the
vagovagal circuitry within the DVC by descending input
from the hypothalamic paraventricular nucleus (PVN)
and lateral hypothalamic area (LHA) constitutes the
primary means whereby higher centres exert a direct
influence over gastric and pancreatic secretion, as well as
stomach and small intestinal motility (Gillis et al. 1989;
Loewy, 1990; Bernardis & Bellinger, 1996).
The possibility that orexin-containing projections to the
DVC play a role in the central regulation of gastric
function was first suggested by Takahashi et al. (1999),
who demonstrated that administration of orexin-A into
the fourth ventricle stimulates gastric acid secretion in
conscious rats. The stimulatory effect of orexin-A on acid
secretion was blocked by atropine and abolished in
vagotomized animals, indicating that it was dependent
upon increases in vagal efferent nerve activity.
Additionally, Hornby and co-workers have shown in
anaesthetized rat that microinjection of orexin-A or -B
into the DMV, but not into surrounding areas, increases
gastric tone and stimulates motility via a vagal dependent
mechanism (Krowicki et al. 2002). These data raise the
possibility that release of orexins within the DMV may
mediate the cephalic phase of normal digestive functions,
characterized by increased acid secretion and gastric
contractions, which occurs in anticipation of feeding
(Powley, 2000).
Recent immunohistochemical studies and results from in
situ hybrization experiments indicate that orexin-1 receptors
are highly expressed in neurones of the rat DMV (Marcus
et al. 2001; Krowicki et al. 2002). Moreover, recordings
obtained in rat medullary slices revealed that orexins
directly depolarize a fraction (approximately 30 %) of
DMV neurones (Hwang et al. 2001), including some that
were identified as preganglionic parasympathetic neurones
based on their retrograde labelling following intra-
peritoneal injection of Fluorogold. These data provide a
cellular basis for the vagally mediated increase in gastric
acid secretion produced following administration of
orexin-A into the fourth ventricle (Takahashi et al. 1999).
Similarly, the stimulation of gastric motor function
produced by microinjection of orexins into the DMV
could arise largely from activation of preganglionic para-
sympathetic neurones providing excitatory cholinergic
innervation to the stomach. Nevertheless, the DMV consists
of a heterogeneous population of neurones (Berthoud et al.
1991; Krowicki & Hornby, 1995), including a number of
functionally distinct groups of abdominal vagal efferent
neurones distinguished according to their neurochemical
phenotype, specific site of innervation within the GI tract,
and/or pattern of connectivity with excitatory or
inhibitory postganglionic motor neurones. Accordingly, it
is important to have information about the site of
projection of the DMV neurone under study if one is to
succeed in relating cellular effects observed in vitro to the
physiological functions of individual vagal efferent
neurones. It should also be mentioned that orexins have
been shown to produce a variety of cellular effects in many
different types of target neurones, typically producing
direct depolarization, but also acting presynaptically to
modulate synaptic input (van den Pol et al. 1998;
Kirchgessner & Liu, 1999; Grudt et al. 2002; Liu et al.
2002). Although studies by Hwang et al. (2001) indicate
that orexins directly excite a group of preganglionic para-
sympathetic DMV neurones, the possibility that orexins
also regulate their activity indirectly by modulating
synaptic transmission in the DMV remains to be
determined.
In the present study, whole-cell recordings were obtained
in rat medullary slices to determine the effects of orexin-A
and orexin-B on the intrinsic membrane properties and
synaptically evoked responses of retrogradely labelled
DMV neurones that project either to the gastric fundus,
corpus, antrum/pylorus, duodenum or caecum. By
correlating the response to orexins in individual DMV












neurones with their site of projection in the GI tract, we
sought to determine whether sensitivity to these peptides is
expressed preferentially in gastric-projecting vagal neurones
or distributed ubiquitously, including among DMV
neurones that project to proximal or distal portions of the
intestine. The electrophysiological effects of orexin-A were
also compared with the responses produced by oxytocin
(OT) in many of the same DMV neurones. Earlier studies
have established that OT-containing neurones of the PVN
provide the major source of descending hypothalamic
input to the DMV (Swanson & Kuypers, 1980; Rinaman,
1998), and OT has been shown to evoke a slow
depolarization in many gastric-related vagal neurones
(Dubois-Dauphin et al. 1992). In addition, OT acts via a
vagal-dependent mechanism to stimulate gastric acid
secretion (Rogers & Hermann, 1985, 1987), similar to
orexin-A, whereas it inhibits gastric contractility tonically
or when microinjected directly into the DMV (Rogers &
Hermann, 1987; Flanagan et al. 1992). Based on these data,
we hypothesized that orexins and OT might exert their
opposing effects on gastric motor activity by acting
selectively or in a differential manner to modulate the
excitability of ‘functionally’ distinct groups of gastric-
related vagal motor neurones. The corollary hypothesis
was also examined, that some gastric-related DMV neurones
will be directly excited by orexin-A and OT, providing the
cellular substrate by which both types of hypothalamic
peptidergic input stimulate gastric acid secretion. A
preliminary account of these data has been presented
previously (Grabauskas & Moises, 2001).
METHODS 
All procedures were performed in accordance with NIH
guidelines and with the approval of the Animal Care and
Utilization Committee of The University of Michigan, Ann Arbor,
MI, USA.
Retrograde labelling
Sprague-Dawley rats (10–12 days olds) of either sex were
anaesthetized with a 4 % mixture of 2-bromo-2-chloro-
1,1,1-trifluorethane (halothane) in air, delivered at 500 ml min_1
via a vaporizer (Fluotec-3, Fraser Harlake, NY, USA). The depth of
anaesthesia was checked by lack of withdrawal reflex to toe pinch
before beginning surgery and maintained constant throughout all
surgical procedures by placing the head of the rat in a custom-
made chamber through which a reduced halothane (1.0–1.5 % in
air) mixture was delivered. The abdominal area was shaved and
cleaned with 70% ethanol, and an abdominal laparotomy was
performed. Crystals of the retrograde tracer 1,1‚-dioctadecyl-
3,3,3‚,3-tetramethylindocarbocyanine perchlorate (DiI; Molecular
Probes, Eugene, OR, USA) were applied to a single region of the GI
tract per rat, according to procedures described by Browning et al.
(1999). Dye was deposited either to the greater curvature of the
gastric fundus or corpus, to the antrum/pylorus, intestinal
duodenum (anti-mesenteric border at the level of the bifurcation
of the hepatic and pancreatico-duodenal arteries) or the caecum
(at the level of the ileo-caecal junction). To confine the dye to the
site of application, crystals of DiI were embedded in a fast
hardening epoxy resin that was allowed to harden for
approximately 5 min. This was followed by washing of the surgical
area with warm sterile saline and blotting of any excess solution
with cotton swabs. The wound was then closed with nylon sutures
(4-0), and the animal allowed to recover for 8–15 days prior to
being killed for electrophysiological study. In 13 experiments the
retrograde tracer DiO (Molecular Probes) was also applied to a
region distinct from that which received application of DiI (DiI on
fundus and DiO on corpus, n = 4; DiI on corpus and DiO on
duodenum, n = 4; DiI on corpus and DiO on antrum/pylorus,
n = 3; DiI on duodenum and DiO on caecum, n = 2)
Brain slice preparation
Coronal tissue slice preparations of rat brainstem were prepared
according to procedures described in detail by Browning et al.
(1999). Briefly, rats were decapitated using a small laboratory
animal guillotine and the whole brain, including the brainstem,
was rapidly removed and placed in ice-cold physiological saline
consisting of (mM): NaCl, 124; KCl, 2.5; CaCl2, 2.5; MgSO4, 1.3;
NaHCO3, 26; NaH2PO4, 1.25; and glucose, 10, gassed with 95 %
O2–5 % CO2 and adjusted to pH 7.3. The cerebellum was removed
and the brainstem transected at the level of the pons and again at a
point several millimetres caudal to the calamus scriptorius
(defined by the caudal-most part of the area postrema). Using a
Vibratome, three to four coronal slices (200 mm-thick) containing
the DVC were cut and placed in a holding chamber, containing
physiological saline maintained at room temperature and
continually gassed with 95 % O2–5 % CO2. The slices were
incubated for at least 1 h prior to electrophysiological study. A
single slice was then transferred to a custom-designed recording
chamber (volume ~500 ml), where it was continuously perfused
(1–2 ml min_1) under submersion with oxygenated physiological
saline (Krebs solution). Slices were normally maintained at room
temperature (most current clamp recordings) or else perfused
with Krebs solution prewarmed to 34 °C for recording of
postsynaptic membrane currents under voltage clamp. Recording
at the higher temperature had the desired effect of increasing the
amplitude and rate of activation of the evoked currents, but had
no appreciable effect on responses produced by orexins or OT.
Therefore, results obtained under these two conditions have been
pooled and are presented together.
Electrophysiological recordings
Prior to electrophysiological recording, retrogradely labelled
DMV neurones were identified using a Nikon E600FN
microscope equipped with TRITC epifluorescence filters. Once a
labelled neurone was identified, its location in the slice was
confirmed under brightfield illumination using DIC (Nomarksi)
optics. Electrodes for stimulating and recording were placed into
position under visual guidance. Unless otherwise indicated,
recordings were performed in neurones that were unequivocally
identified as labelled with DiI.
Whole-cell patch-clamp recordings were performed using patch
pipettes (5–6 MV) fashioned from 1.5 mm o.d. borosilicate
filament glass and filled with a solution containing (mM):
potassium gluconate, 135; KCl, 10; Hepes, 10; EGTA, 10; MgCl2,
1.0; CaCl2, 1.0; ATP, 2.0; GTP, 0.5. In some experiments, CsCl
(145 mM) was substituted for  potassium salts in the pipette
solution to examine for effects of blockade of voltage-dependent
K+ conductances on membrane responses to orexins. Recordings
of spontaneous and miniature IPSCs (mIPSCs) were made with a
pipette solution that contained 135 mM KCl in place of potassium
gluconate. Under these conditions, the amplitudes of IPSCs and
mIPSCs are enhanced and appear as inward currents when












neurones are clamped at _60 mV, owing to a positive shift in the
Cl_ equilibrium potential. All recording solutions were adjusted
to pH 7.2–7.3 with KOH and had an osmolarity of 275–
292 mosmol l_1. The data were recorded using an Axopach 1D
amplifier (Axon Instruments, Union City, CA, USA), filtered at
3 kHz, digitized via a Digidata 1200C interfaced to a Pentium-
based microcomputer, stored and later analysed off-line using
pCLAMP 8 software (Axon Instrument, Union City, CA, USA).
Correction was made for the tip potential (approximately 8 mV)
and only those recordings having a series resistance (i.e. pipette +
access resistance) < 15 MV were used.
Postsynaptic excitatory and inhibitory currents (EPSCs and
IPSCs) were evoked by delivering constant current rectangular
pulses (0.5 ms duration) via a tungsten bipolar stimulating
electrode placed under visual control in the nucleus
commissuralis or medialis of the NTS. Single shocks or pairs of
stimuli (spaced 100 ms apart) were applied every 30 s, and the
stimulus intensity was adjusted to evoke submaximal (~65 % max)
excitatory or inhibitory currents that ranged in amplitude from 50
to 300 pA. The criteria for detecting spontaneous synaptic currents
were fast rise times (< 1 ms) and exponential decays, with 20 pA
(at least twice baseline noise) used as the detection limit for
minimum PSC amplitude. Frequencies of spontaneous synaptic
events were obtained over continuous periods of recording, lasting
from 2 to 5 min, and between 250 and 400 consecutive PSCs were
measured for determinations of mean amplitudes.
Drug application
Drugs were applied to the bath in known concentrations via a
series of manually operated switching valves. Because of the
long duration of effects encountered with orexins or OT,
superfusion of peptides was terminated once a plateau effect
was observed. When experiments were performed to determine
concentration–response relationships, the subsequent superfusion
of different concentrations of peptide was randomized and a
washout period of at least 30 min was allowed between individual
trails. Recordings of spontaneous IPSCs and IPSCs evoked in
response to stimulation of the NTS were carried out in the
presence of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX;
20 mM) and 2-amino-5-phosphonovaleric acid (APV; 50 mM)
to eliminate contamination by EPSCs. Administration of these
antagonists at the concentrations indicated has been shown
previously to eliminate spontaneous and evoked glutamatergic
synaptic currents in DMV neurones, without affecting GABA-
mediated inhibitory synaptic events (Willis et al. 1996).
Conversely, recordings of stimulation-evoked EPSCs were carried
out in the presence of bicuculline methiodide (BMI, 30 mM) or
picrotoxin (100 mM) to selectively eliminate spontaneous and
evoked GABAergic inhibitory postsynaptic currents (Browning &
Travagli, 1999). For all experiments with PSCs, a minimum of 10
control excitatory or inhibitory postsynaptic current responses
were obtained prior to application of drug and the effects were
assessed using each neurone as its own control, i.e. the results
obtained after administration of a receptor antagonist or peptide
were compared to those obtained before drug administration.
Data and statistical analysis
Recordings were considered acceptable if the membrane
remained stable at the holding potential (usually _60 mV), the
resting membrane potential of the neurone was more negative
than _50 mV, and the neurone generated overshooting action
potentials. The input resistance of recorded neurones was
calculated by measuring the amplitude of electrotonic potentials
evoked in response to passage of a series of 20 pA constant current
pulses (400 ms in duration) through the recording electrode,
determined before the onset of any inward rectification. Data are
presented in the text as means ± S.E.M. Statistical analysis was
performed using Student’s paired t test and the significance was
accepted at the level P < 0.05. Group differences in responsiveness
to orexins or OT as a function of the GI projection of DMV
neurones were determined using the chi-square test. Analysis of
PSC frequency and amplitude was conducted with commercially
available Mini Analysis software (Synaptosoft, Inc., Decatur, GA,
USA). This program detects and measures spontaneous synaptic
events according to the amplitude, rate of rise, duration and area
under the curve (fc). Statistical comparisons of the extracted
amplitude and interspike interval distributions for PSCs were
obtained using the nonparametric Kolmogorov–Smirnov test,
with a significant difference being set at P < 0.01.
Drugs
Orexin-A and Orexin-B were purchased from Bachem (King of
Prussia, PA, USA). DiI was obtained from Molecular Probes
(Eugene, OR, USA). Tetrodotoxin (TTX) was purchased from
Alamone Laboratories (Jerusalem, Israel). Oxytocin, bicucculine
methiodide (BMI), picrotoxin, CNQX, APV and all other
chemicals were purchased from Sigma-Aldrich-RBI (St Louis,
MO, USA).
RESULTS 
Membrane properties of DMV neurones
The results are based on recordings obtained from 219
DMV neurones in medullary slices from 98 rats, ranging in
age from 18 to 27 days. The vast majority of these recordings
(n = 204) were from neurones that were retrogradely
labelled by application of DiI to the gastric fundus (n = 50),
corpus (n = 85), antrum/pylorus (n = 24), duodenum
(n = 27) or caecum (n = 18). Depending on the placement
of DiI, four to ten unequivocally labelled neurones could be
identified within the DMV in each slice preparation,
interspersed among a background of numerous unlabelled
cells (Fig. 1). In our labelling technique, applications of DiI
were restricted to loci along the greater curvature of the
stomach or anti-mesenteric site of the intestine, as these
areas contain few or no fibres of passage, but rather vagal
nerve terminals (Berthoud et al. 1990). Thus, the
retrograde labelling of individual somata was likely to be
selective for the specific GI region to which application of
DiI was made. In addition, in the 13 experiments in which
both DiI and DiO were placed on separate regions of the GI
tract, double labelling was never observed (i.e. no
neurones showed the presence of both DiI and DiO),
arguing in favour of the selectivity of our tracing technique
(see Fig. 1B).
DMV neurones used in this study showed no apparent
age-related differences in either their basic electro-
physiological properties or responsivess to orexins, and
therefore results obtained from neurones examined at
days 18 to 27 of maturation have been pooled. In current
clamp recordings, retrogradely labelled DMV neurones
had a mean resting membrane potential of _56 ± 1.3 mV
(range, _54 to _62 mV), mean input resistance of












701 ± 25 MV (range, 665 to 790 MV), and overshooting
action potentials with mean amplitude of 79.2 ± 5.1 mV
(range, 74.2 to 82.8 mV) and duration of 3.1 ± 0.2 ms
(range, 2.8 to 3.4 ms). These values compare favourably
with those reported by Browning et al. (1999) for DMV
neurones with the corresponding GI projection, although
measurements of membrane input resistance were notably
higher due to recording at room temperature as opposed
to 34 °C (as done in voltage-clamp recordings). Similarly, a
large majority (67 %) of the DMV neurones we recorded
were spontaneously active, with no significant difference
in mean firing rate observed between the different
neuronal groups (0.98 ± 0.22 spikes s_1, range
0.1–2 spikes s_1).
Effects of orexin-A and orexin-B in DMV neurones
The electrophysiological effects of orexin-A or orexin-B
were examined in current-clamp recordings from 102
DMV neurones, including 87 that were identified as GI-
projecting by their labelling with DiI. For these
experiments, the membrane potential of the neurone was
held at _60 mV by injecting constant current through the
recording electrode to prevent spontaneous firing in the
absence of peptide. Bath adminstration of orexin-A at a
saturating concentration (300 nM) produced excitation in
46 % of the DMV neurones (47 total, including 9/15
unidentified neurones), manifested by a slow membrane
depolarization (Fig. 2A). In 43 of the neurones in which
orexin-A produced depolarization, this was accompanied
by a marked increase in spontaneous firing that for the
group averaged 2.8 ± 1.1 spikes s_1 (P < 0.05). Both the
orexin-induced depolarization and increase in firing were
of prolonged duration, continuing unabated for
15–45 min before returning to control levels following
washout of peptide from the bath (Fig. 2A). The excitatory
effects of orexin-A were also concentration dependent in a
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Figure 1. Identification of gastric-projecting DMV neurones in brainstem slices by retrograde
labelling with DiI
A, brightfield photomicrograph at low magnification of a coronal slice through the caudal medulla at the
level of the DVC. B, fluorescence photomicrograph of the same field of view as in A, illuminated through
filters selective for TRITC (red) or FITC (green). Note the labelling of distinct groups of neurones following
application of DiI to the gastric corpus (red) and application of DiO to the antrum/pylorus (green),
respectively. Moreover, no instances were found in which DiI and DiO were co-localized in the same DMV
neurone following apposition of these tracers to different regions of the GI tract in the same animal (n = 13).
C, brightfield photomicrograph (DIC optics) at higher magnification of a region in medial DMV that
contained neurones labelled with DiI but not DiO. Arrows indicate two corpus-projecting DMV neurones
that were identified by the presence of DiI under fluorescence illumination. D, fluorescence (TRITC)
photomicrograph of the same field of view as in C reveals the same two DiI-labelled neurones (marked by
arrows). Scale bars represent 100 mm in panels A and B, 20 mm in panels C and D. Abbreviations: cc, central












given DMV neurone (Fig. 2B, top and middle traces).
However, the magnitude of the depolarization to a
saturating concentration of peptide varied greatly between
cells (8.1 ± 1.9 mV at 300 nM; 5 to 22 mV range, n = 32),
and measurement of these responses was often obscured
by the induction of firing. Therefore, evaluation of the
concentration–response relationship for orexin-A-induced
excitation was conducted in DMV neurones recorded
under voltage clamp during pharmacological blockade of
sodium-dependent spike activity (see below).
Administration of orexin-B (300 nM) produced
depolarization and/or increased firing in a similar
percentage of GI-projecting DMV neurones (48.6 %, 17 of
35), including 11 that also responded with excitation to
orexin-A (Fig. 2B). The excitatory effects of orexin-B
appeared indistinguishable from those of orexin-A and
were observed over a similar range of concentrations
(30–500 nM). Among 23 GI-projecting neurones that were
tested with both peptides, 11 were excited by both
orexin-A and orexin-B, 4 responded only to orexin-A, and
8 were unresponsive to either peptide.
DMV neurones respond to orexins in a
viscerotopically organized manner
Earlier studies have shown that the majority of pre-
ganglionic motor neurones in the rat DMV are involved in
regulating gastric function (Shapiro & Miselis, 1985), with
the extent of vagal parasympathetic control over GI
activity declining progressively as one proceeds distally
from the duodenum into the colon (Berthoud et al. 1991).
Given these considerations, we sought to determine whether
responsiveness to orexins shows regional expression in
preganglionic vagal motor neurones according to their site
of projection in the GI tract. Table 1 summarizes the
results from 87 recordings in which we compared the
ability of orexin-A (300 nM) to excite DMV neurones
labelled following placement of DiI to the gastric fundus
(n = 22), corpus (n = 21), antrum/pylorus (n = 13),
duodenum (n = 18) or caecum (n = 13). We found that
responsiveness to orexin-A was preferentially expressed in
gastric-projecting DMV neurones (69 % of fundus and
corpus-projecting cells, P < 0.05) and rarely encountered
in intestinal-projecting neurones, particularly among
those providing innervation to more distal portions of the
gut (cf. 19 % of duodenal-projecting versus only 8 % of
caecum-projecting cells). Moreover, the responsiveness of
gastric-projecting DMV neurones to orexin-A showed
regional variations, with excitatory effects produced in a
high percentage (70 %) of vagal motor neurones that
innervate the fundus (15 of 22) or corpus (15 of 21), but in
only 3 of 13 neurones identified as projecting to the
antrum/pylorus (23 %, P < 0.05 compared to fundic or
corpus neurones). On the other hand, the probability that a
given neurone showed sensitivity to orexin-A bore no
obvious relationship to its anatomical localization within
the DMV. Thus, roughly 63 % of gastric-projecting
neurones located in rostral DMV anterior of the area
postrema (8 of 13) or in the caudal DMV, posterior to the
obex (7 of 11), were excited by orexin-A (300 nM),
compared to 74 % (15 of 19) of neurones examined that
were localized to the intermediate portion of the nucleus
(extending from the anterior border of the area postrema
to the obex, as defined by Loewy (1990).
Mechanism of orexin-induced excitation
Additional kinds of experiments were performed to
examine the cellular mechanism(s) responsible for the
orexin-induced excitation in DMV neurones. For these
experiments, corpus- or fundus-projecting neurones were
targeted for study because of their high level and uniform
pattern of responsiveness to orexin peptides. The
depolarizing responses of DMV neurones to orexin-A
(n = 13) or orexin-B (n = 5) were examined during
blockade of synaptic transmission with tetrodotoxin
(TTX) to determine whether the excitatory effects of the
peptides were mediated directly, independent of an action
on neighbouring neurones. Administration of TTX (2 mM)
eliminated sodium-dependent spike activity in the slice as
evidenced by blockade of current-evoked action potential
firing. In 16 of 18 neurones examined, the depolarizing
responses to orexin-A or orexin-B continued unabated in
the presence of TTX (Fig. 2B), suggesting they resulted
from the activation of postsynaptic receptors and were not
dependent on impulse-dependent synaptic transmission.
Under these conditions, a small, but significant increase in
membrane resistance (112 ± 0.9 %, range 107–120 %,












n = 11, P < 0.05) was seen to accompany the depolarizing
response to either form of orexin, indicating further that
the peptides increase excitability in DMV neurones in part
by decreasing an outward ionic conductance. Moreover, in
all but two of the neurones, administration of orexins in
the presence of TTX induced the repetitive firing of
spontaneous, low amplitude spike discharges (Figs 2B and
3). These TTX-insensitive spike discharges were abolished
by bath superfusion of the non-selective Ca2+ channel
blocker Cd2+ (300 mM; 3 of 3 neurones tested), and
therefore most likely represented calcium spikes mediated
via influx of Ca2+ through voltage-gated Ca2+ channels
(Fig. 3). On the other hand, perfusion of the slice with
Cd2+ had no significant effect on the amplitude or duration
of the orexin-induced depolarization. The latter result
argues against the likelihood that the orexin-induced
depolarization resulted from changes in Ca2+ conductance,
while providing additional evidence that these responses
were mediated directly via activation of postsynaptic
orexin receptors.
To further characterize the conductance(s) responsible for
the depolarizing effect of orexin-A, DMV neurones were
recorded in voltage-clamp mode at 34 °C. In the first series
of experiments, neurones (n = 17) were held at _60 mV in
Krebs solution containing TTX (2 mM) and orexin-A
administered over a threefold range of concentrations
(10–1000 nM) in randomized order, to determine the
concentration–response relationship for peptide-induced
changes in holding current. Administration of orexin-A at
or in excess of 30 nM induced a slowly developing inward
current, whose peak amplitude at maximal concentrations
of peptide averaged _72 ± 11 pA (42 to 132 pA range,
n = 11) (Fig. 4). The graph in Fig. 4B shows the
concentration–response relationship for the orexin-A-
induced inward current, generated by pooling results
from three to six neurones, tested with at least three
concentrations of peptide. The concentration–response
relationship for the orexin-A-induced inward current was
relatively narrow with a threshold concentration of 30 nM,
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Figure 2. Orexins directly depolarize DMV neurones and increase spike firing
A, perfusion of orexin-A (top trace) or orexin-B (lower trace) produced depolarization, accompanied by an
increase in spontaneous firing, in two different gastric-projecting DMV neurones. Downward deflections in
the traces are electrotonic potentials induced by passage of hyperpolarizing constant current pulses through
the recording electrode that were used to measure membrane input resistance. Note that the amplitudes of
the electrotonic potentials were increased during the orexin-induced depolarizations, indicating that the
peptides increased membrane input resistance. The current monitor directly below the trace of membrane
voltage (in A ) illustrates the time during the orexin-induced depolarization that the membrane potential was
returned to the resting level by passage of hyperpolarizing current. B, recordings from a single DMV neurone
obtained during perfusion of the slice with TTX (2 mM) to block impulse-dependent synaptic transmission.
Administration of orexin-A or orexin-B produced concentration-dependent membrane depolarization via a
postsynaptic action. Both peptides also promoted the occurrence of spontaneous low amplitude spike
discharges that were TTX insensitive. The holding potential was _60 mV (top) and _62 mV (bottom) for the












estimated EC50 of 100 nM and maximal response produced
at 300 nM of the peptide.
In a subsequent series of experiments (n = 6), we examined
the reversal potential for the orexin-induced inward
current. Steady state current–voltage (I–V) relationships
were determined for each neurone in normal Krebs
solution containing TTX (2 mM) and during superfusion
of similar media containing orexin-A (300 nM), and the
corresponding pairs of currents recorded at each potential
were subtracted to reveal the I–V relationship for the
peptide-induced inward current (Fig. 5A). The slope
conductance of steady-state I–V curves measured between
_100 and _50 mV was decreased by orexin-A (2.8 ± 0.3 vs.
3.2 ± 0.5 nS, P < 0.05) in 5 of 6 neurones. In these cells, the
I–V relationship for the orexin-induced current was
essentially linear over the same range of potentials, as
shown for example by the results from a representative
experiment depicted in Fig. 5B. In addition, the
extrapolated reversal potential of the orexin-induced
inward current was _99 ± 2.4 mV, which was close to that
predicted for a pure K+ conductance (_107 mV) under our
recording conditions ([K+]ext = 2.5 mM, 34 ° C). In the
remaining neurone, the steady state I–V curve for the
orexin-induced current showed a parallel shift and did not
reverse polarity over the entire voltage range examined.
Currents of this type have been described previously in
DMV neurones (Hwang et al. 2001) and were attributed to
a combined action of orexin involving inhibition of a
resting K+ conductance and activation of non-selective
cation channels. It was also suggested that this is the
primary mechanism by which orexins directly excite DMV
neurones in the rat, although this conclusion was based on
sampling from an undefined population of cells (Hwang et
al. 2001).
The results from the studies above are more consistent
with a reduction in K+ conductance as the primary basis
for the orexin-induced postsynaptic excitation in gastric-
projecting DMV neurones. To test this hypothesis,
additional types of experiments were conducted under
voltage clamp in a separate group of corpus-projecting
DMV neurones (n = 28) and responses measured to a
single application of orexin-A (300 nM). In the first series,
depolarizing voltage ramps (20 mV s_1) were used to
determine the steady-state I–V relationship for the
orexin-A-induced inward current over an extended range
of membrane potentials (_140 to _40 mV) and the
current was examined for reversal in its polarity. In 8 of 11
recordings obtained in normal Krebs solution, the orexin
I–V curve was essentially linear between _60 and _125 mV,
and in these neurones the orexin-A-induced inward current
reversed at membrane potentials (106 ± 3.2 mV) nearly
identical to EK (Fig. 6A). In the three remaining neurones,
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Figure 3. Orexin-A promotes Ca2+-dependent spike discharge in DMV neurones
A, administration of orexin-A (300 nM) in the presence of TTX evoked a prolonged discharge of low
amplitude spikes, which occurred despite little change in resting membrane potential. This TTX-insensitive
spike activity was reversibly eliminated by administration of the non-selective Ca2+ channel blocker, Cd2+
(300 µM), indicating it consisted of Ca2+-dependent action potentials. The neurone was current-clamped at
_60 mV holding potential. B, family of membrane responses (upper traces) to passage of constant current
hyperpolarizing (_0.1 nA) and depolarizing (+0.02 nA) pulses (lower traces) through the recording
electrode at the times and under the conditions indicated (corresponding to letters a–d) in the voltage trace
(A). Orexin-A promoted the discharge of Ca2+-dependent action potentials at resting and depolarized levels












orexin-A induced an inward current that decreased with
hyperpolarization (between _40 and _90 mV), but did not
reverse in the entire voltage range examined (Fig. 6B).
To further evaluate the involvement of K+ conductance,
steady state I–V curves for orexin-A-induced currents
were measured in a high-K+ (15 mM) Krebs solution in five
additional neurones. We noted in our earlier studies that
the response to orexin-A typically declined with each
successive application of peptide (but see the neurone
depicted in Fig. 5). To prevent this from biasing the results,
the effect of orexin-A on membrane current was
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Figure 4. Concentration–response relationship for orexin-A-induced inward current
A, family of current traces recorded in a DMV neurone voltage-clamped at _60 mV holding potential in
response to administration of increasing concentrations of orexin-A. B, concentration–response
relationship for inward shift in holding current produced by orexin-A (10–1000 nM). Each point (filled
squares) represents the mean ± S.E.M. (capped bars) of the normalized orexin-induced inward current,
generated by pooling results from 3–6 neurones, tested with at least three concentrations of peptide. The line
was fitted to the data points using the Hill equation: I/Imax = C
n/(C n + EC50
n), where I is the measured current
at drug concentration C; EC50 is the concentration of drug producing a 50 % response, and n is the Hill
coefficient.
Figure 5. I–V relationship for the orexin-induced inward current in DMV neurones
Traces in A illustrate the change in orexin-A-induced inward current recorded in a gastric-projecting DMV
neurone as a function of the holding potential. Note the progressive decrease in magnitude of the orexin-
induced inward current with membrane hyperpolarization. B, I–V relationship for the inward current
responses for the neurone depicted in A, generated by plotting the peak amplitude of the peptide-induced
current as a function of the holding potential. In this neurone the I–V relationship was essentially linear over
the voltage range of _50 to _90 mV and yielded an estimated reversal potential of _96 mV for the peptide-












determined in high-extracellular [K+], without prior
testing in normal Krebs solution, and neurones were
included for analysis if the orexin-induced current showed
a clear reversal potential. In four of five neurones tested,
the I–V curves revealed orexin-induced currents that
reversed between _65 and _58 mV (Fig. 6C), with the
reversal potential shifting to _62 ± 6 mV in 15 mM
extracellular K+, which is close to the value predicted for a
pure K+ conductance under these conditions (_60.2 mV at
34 ° C). We also examined for dependence of the orexin-
induced inward current on K+ conductance by recording
from DMV neurones using patch pipettes filled with CsCl
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Figure 6. Decrease in K+ conductance largely accounts for orexin-induced inward current in
gastric-projecting DMV neurones
A, superimposition of I–V relationships generated to a voltage ramp from _140 mV to _40 mV in normal
Krebs (control) and during administration of orexin (300 nM). Administration of orexin to this neurone
decreased whole-cell slope conductance and induced a linear inward current over the range of _125 to
_60 mV. A subtraction trace (lower panel) shows the orexin-induced current reversed near EK (approx.
_107 mV) (lower panel). B, I–V curves from a different corpus-projecting DMV neurone in which orexin-A
induced a small inward current that did not reverse over the entire voltage range tested (lower panel).  C, I–V
relationship for the orexin-induced current response of another DMV neurone determined during perfusion
of high-K+ (15 mM)-containing Krebs solution. In this neurone, the orexin-induced current was
accompanied by little change in slope conductance over an extended range of membrane potentials, yet
reversed near to EK (_60 mV) as predicted for these recording conditions. D, average amplitude of orexin-A-
induced inward current (measured at _60 mV holding potential) for DMV corpus-projecting DMV
neurones recorded with patch pipettes filled with potassium gluconate (n = 18) or CsCl (n = 12). The













(145 mM), which blocks a variety of K+ channels. Under
these conditions, administration of orexin did not produce
a significant change in membrane current in any of the 12
neurones examined (Fig. 6D). Taken together, these data
suggest that orexin-A produces direct excitation in a
majority of gastric-projecting DMV neurones via a Cs+-
sensitive mechanism, involving reduction of a K+ current.
Effect of orexins on synaptic currents in DMV
neurones
Orexins have been shown to modulate synaptically evoked
activity in a variety of target neurones, resulting in actions
that can reinforce as well as oppose the direct excitatory
effects of the peptides on neuronal excitability (van den
Pol et al. 1998; Kirchgessner & Liu, 1999; Liu et al. 2002).
To examine for a presynaptic action of the peptide on
afferent input to DMV neurones, pairs of excitatory or
inhibitory postsynaptic currents (EPSCs and IPSCs) were
evoked by repetitive electrical stimulation in NTS and the
averaged responses to 10 stimulation trials compared
before, during and after washout of orexin-A (300 nM)
from the bath. Electrical stimulation delivered to the NTS
subnucleus medialis or commissuralis evoked inwardly
directed EPSCs, outward IPSCs, or biphasic EPSC–IPSC
responses in 38 of 51 DMV neurones, recorded at _60 mV
holding potential. The inward synaptic currents were
reduced in amplitude and duration by administration of
APV (50 mM) and blocked completely by addition of
CNQX (20 mM) alone (6 of 11 neurones) or when applied
in combination with APV (Fig. 7A, remaining five
neurones). These results are congruent with earlier reports
that document the involvement of both NMDA-type and
AMPA-type glutamate receptors in the generation of
EPSCs in rat DMV neurones (Willis et al. 1996; Bertolino
et al. 1997; Browning et al. 2002). Conversely, the outward
components of all postsynaptic currents (PSCs) were
blocked by bath application of picrotoxin (4/4 neurones)
or BMI (30 mM) (10 of 10 neurones, Fig. 7B), consistent
with previous studies that indicate mediation of these
inhibitory responses via release of GABA and activation of
postsynaptic GABAA receptors (Travagli et al. 1991;
Bertolino et al. 1997; Browning & Travagli, 1999).
Additionally, we found that administration of BMI
increased the amplitude of evoked EPSCs in 5 of 7
neurones examined (Fig. 7C), suggesting that focal
electrical stimulation to a localized site within the NTS
might activate both inhibitory and excitatory inputs that
converge onto a single DMV neurone.
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Figure 7. Pharmacological dissection of
glutamatergic EPSCs and GABAergic IPSCs evoked
in DMV neurones in response to electrical
stimulation in NTS subnucleus commisuralis or
medialis
The traces in panels A–C represent synaptic currents evoked
in three different gastric-projecting DMV neurones. A, the
amplitude of the NTS-evoked EPSC was slightly enhanced
during perfusion of BMI (30 µM), whereas it was reduced by
administration of APV, a selective NMDA-type glutamate
receptor blocker. Administration of APV (50 mM) in
combination with CNQX (20 mM), an AMPA-type
glutamate receptor blocker, completely abolished the EPSC.
B, the NTS-evoked IPSC recorded in another neurone was
largely eliminated during superfusion of BMI (30 mM), a
selective GABAA receptor antagonist. C, stimulation in NTS
subnucleus medialis evoked synaptic currents in a third
neurone that were sensitive to BMI and glutamate receptor
antagonists. In this neurone, blockade of an IPSC following
administration of BMI unmasked a small EPSC that was
eliminated by the combined application of APV and CNQX.












The effects of administration of orexin-A or orexin-B
(300 nM) were examined on stimulation-evoked excitatory
or inhibitory currents in 31 GI-related DMV neurones, of
which 17 projected to the gastric fundus or corpus, 4 to the
antrum/pylorus, 7 to the duodenum, and 3 innervated the
caecum. Superfusion of orexin-A or orexin-B had no
significant effect on the peak amplitude of the NTS-evoked
EPSCs in any neurones (n = 9), regardless of their site of
projection in the GI tract (95 ± 3.9 % of control,
P = 0.35). On the other hand, the peak amplitude of NTS-
evoked IPSCs was reversibly increased by administration
of either orexin-A or orexin-B in 5 of 22 neurones tested
(115 ± 6.1 %, P < 0.05, Fig. 8A). In addition, in three of
the five neurones administration of orexin-A unmasked
outward currents that showed sensitivity to blockade by
TTX (2 mM) and by the selective GABAA receptor
antagonist BMI (30 mM) (Fig. 8B). Interestingly, all five
neurones were identified as projecting either to the fundus
or corpus; however, none of them showed excitation or a
depolarizing shift in holding current (when clamped at
_60 mV holding potential) in response to application of
the peptide.
The results from the latter experiments suggest that
orexins may act indirectly to modulate excitability in a
small subset of gastric-projecting DMV neurones by
facilitating the evoked release of GABA from NTS
neurones. In an initial test of this hypothesis, we next
examined whether the enhancement of NTS-evoked
IPSCs by orexin-A was associated with a change in the
paired-pulse ratio. The ratio of the amplitude of two
postsynaptic currents evoked a few milliseconds apart has
been used routinely to determine the pre- versus
postsynaptic site of drug action (Trombley & Westbrook,
1992; Travagli & Williams, 1996), with a change in the
ratio being taken as an indication of a presynaptic effect.
Figure 9 illustrates the results from a representative
experiment conducted in DMV neurones that showed
peptide-induced enhancement of the NTS-evoked IPSC.
When two IPSCs were evoked 100 ms apart in this DMV
neurone, the second IPSC (S2) was smaller than the first
(S1). In the presence of orexin-A (300 nM) the paired-pulse
ratio (S2/S1) increased from 0.64 in control to 0.78
(Fig. 9C), suggesting that the enhancement of the evoked
IPSC resulted from actions of the peptide at a presynaptic
site. Results from four neurones examined in this manner
revealed that the paired-pulse ratio obtained from
averaging all of the traces in the presence of orexin-A was
larger than the corresponding ratio obtained from traces
generated under control conditions (0.83 ± 0.8 vs.
0.58 ± 0.7, P < 0.05).
Next, we examined for an effect of orexin-A on
spontaneous IPSCs (sIPSCs) to determine whether the
facilitation of inhibitory input onto DMV neurones arose
indirectly from excitation of GABAergic NTS neurones or
resulted from actions of the peptide on NTS nerve
terminals. In these experiments, recordings were obtained
from corpus-projecting DMV neurones using KCl-filled
pipettes and CNQX (20 mM) and APV (50 mM) included in
the bath solution to eliminate contamination by EPSCs
(see Methods). Using KCl-filled pipettes shifted the
reversal potential for Cl_ to near 0 mV, such that sIPSCs
appeared as inward currents and were more readily
detected (compared with potassium gluconate recordings),
being of larger amplitude at the holding potential
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Figure 8. Orexin-A enhances synaptic
inhibition in a subset of DMV neurones
A, administration of orexin-A enhanced the
amplitude of IPSCs evoked by electrical
stimulation in NTS subnucleus commisuralis.
Responses were recorded at _60 mV holding
potential. B, current traces recorded in two
different neurones illustrate the unmasking of a
tonic inhibitory outward current following
administration of orexin-A (300 nM). In the
neurone depicted in Ba, administration of
orexin-A (bar) induced a prolonged outward
current that was sensitive to blockade by TTX
(2 µM) (lower trace). In a second neurone (Bb),
the orexin-induced outward current was blocked
entirely by administration of the selective GABAA
receptor antagonist, BMI. Neurones depicted in B













(_60 mV). The frequency of sIPSCs was reversibly
increased by orexin-A (300 nM) in 4 of 20 neurones tested
(Fig. 10), which is in keeping with the low incidence of
neurones showing enhancement in stimulation-evoked
inhibition, as described above. In these four neurones,
orexin-A increased the frequency of sIPSCs by 73–345 %
and also enhanced the mean amplitude of the synaptic
current (from 45 ± 7 pA to 79 ± 6 pA, P < 0.01) (Fig. 10B).
No effect of orexin-A on sIPSC frequency or amplitude
was observed in the remaining 16 neurones.
Finally, to determine if the increase in IPSC frequency
induced by orexin-A was due to stimulation of NTS
neurone activity, the peptide was applied during blockade
of impulse-dependent release with TTX in five cells,
including three in which sIPSC frequency was increased
by orexin-A in normal Krebs solution. As shown in
Fig. 10C, the frequency of mIPSCs was not affected by
administration of orexin-A in any of these corpus-
projecting DMV neurones (P > 0.05). In all cases, these
spontaneous inward currents were blocked by BMI
(30 mM), indicating that they were mIPSCs (Fig. 10C).
DMV neurones show differential responsiveness to
orexins and OT
Electrophysiological recordings obtained from DMV
neurones in vivo and in brainstem slice preparations
demonstrate that a large percentage of preganglionic vagal
motor neurones are endowed with functional OT
receptors, whose activation causes an increase in neuronal
excitability (McCann & Rogers, 1990; Dubois-Dauphin et
al. 1992; Raggenbass & Dreifuss, 1992). Others have shown
that microinjection of OT into the DMV in anaesthetized
rats increases the excitability of neurones that receive
excitatory drive from gastric vagal mechanoreceptors,
thereby potentiating vago-vagal reflexes that modulate
gastric motility and secretion (Rogers & Hermann, 1987;
McCann & Rogers, 1990). On the other hand, blockade of
central OT receptors has been reported to increase baseline
gastric motility in adult rats (Flanagan et al. 1992),
suggesting that endogenous OT may exert tonic inhibitory
control over specific components of vagal efferent outflow
and thus counterbalance the stimulatory effects of orexins
on gastric motor function. Presuming this model to be
true, we hypothesized that OT and orexins may act either
selectively or in a differential manner to modulate the
excitability of distinct populations of gastric-projecting
DMV neurones. To test this hypothesis, we compared the
ability of orexin-A and OT to produce excitation in the
same DMV neurones, using membrane depolarization
and/or increase in firing as an index of postsynaptic
responsiveness, and correlated the sensitivity of individual
vagal neurones to each peptide with their site of projection
in the GI tract. The effects of bath administration of OT in
saturating concentrations (typically 300 nM) were
examined in current-clamp recordings from 40 GI-
projecting DMV neurones that were also tested for
responsiveness to orexin-A (300 nM). Slightly less than half
(18 of 40) of the DMV neurones responded to OT, with the
typical response consisting of a slow depolarization and/or
increase in spontaneous firing, associated with little change
or a small increase in membrane conductance (Fig. 11A).
The excitatory responses to OT appeared remarkably
similar to those produced by orexin-A in terms of their
amplitude and prolonged time course. However, only a
few DMV neurones were encountered that responded with
excitation to both peptides. Table 2 summarizes the results
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Figure 9. Enhancement of the IPSC by orexin-A is accompanied by a change in the paired-
pulse ratio
A, representative traces showing pairs of IPSCs evoked 100 ms apart before and during administration of
orexin-A (300 nM). Orexin-A increased the amplitude of the NTS-evoked inhibitory currents. B, the
alteration of the paired-pulse ratio (S2/S1) for the traces depicted in A is easily seen after normalizing to
control (pre-drug) amplitude the amplitude of the IPSC evoked by the first pulse (S1). Traces are the average
of 10 trials each. Holding potential was _60 mV. C, the paired-pulse ratio compares the amplitude of the
second current (S2) with that of the first current response (S1), which in this neurone was increased from 0.64












from 40 experiments in which excitatory responsiveness to
OT and orexin-A was compared in the same DMV
neurones, categorized according to their site of GI
projection. Two major findings are apparent from these
data: first, only 6 of 18 neurones that were excited by OT
were also responsive to orexin-A, and most of these (4 of 6)
innervated the gastric fundus. Second, in contrast to what
was found with orexins (see Table 2), responsiveness to OT
was uniformly expressed among DMV neurones that
project to the different regions of the stomach or to the
duodenum. From these experiments we conclude that
orexin-A and OT exert their respective influence on
specific components of vagally dependent GI functions
primarily by modulating excitability of distinct groups of
GI-projecting vagal neurones, rather than through
differential actions exerted on a common pool of vagal
motor neurones.
DISCUSSION 
The present study demonstrates that the hypothalamic
peptides orexin-A and orexin-B have excitatory effects in
many DMV neurones in the rat, including a large
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Figure 10. Effect of Orexin-A on inhibitory synaptic input
A, current traces recorded from a voltage-clamped corpus-projecting DMV neurone show an increase in
spontaneous IPSCs induced by administration of orexin-A (300 nM). Holding potential was _60 mV. The
lower records correspond to the areas designated in the upper traces, depicted at expanded time scale.
Recordings were obtained in the presence of APV (50 mM) and CNQX (20 mM) to eliminate EPSCs and using
KCl-filled electrodes, such that Cl_-mediated IPSCs appear as inward currents. The stimulatory effect of
orexin-A on IPSC frequency was reversible, with recovery of PSC frequency to the control level following
40 min washout of peptide from the bath. B, cumulative distributions of PSC amplitude (left) and inter-
event intervals (right) for the same cell before and during the application of orexin-A indicate that the
peptide increased the amplitude (P < 0.05) and frequency of sIPSCs (P < 0.05). C, traces from another
corpus-projecting DMV neurone recorded in the presence of TTX (2 mM) reveal no effect of orexin-A
(300 nM) on the frequency of mIPSCs. The occurrence of mIPSCs was abolished by administration of the












percentage of preganglionic vagal motor neurones that
innervate the upper GI tract. The excitatory effects of
orexin peptides were manifested by a prolonged
membrane depolarization, accompanied by an increased
frequency of action potential discharge. The depolarizing
responses to orexins persisted in the presence of TTX and
during blockade of Ca2+-dependent synaptic activity with
Cd2+, indicating that they resulted from a direct action of
the peptides on the recorded neurone, rather than via
interactions at a presynaptic site. In addition, orexins
induced a barrage of low amplitude spike discharges that
were unaffected by TTX, but were eliminated in a
reversible manner by administration of Cd2+. The latter
results indicate that these peptides promote Ca2+-
dependent spike firing in DMV neurones, presumably via
enhancement of Ca2+ influx through voltage-dependent
Ca2+ channels, similar to the effects found in locus
coeruleus neurones (Horvath et al. 1999b) and in
hypothalamic neuronal cultures (van den Pol et al. 1998).
Adding support to this are results from preliminary studies
that demonstrate the ability of orexin-A to modulate
specific components of depolarization-evoked whole-cell
Ca2+ current in acutely dissociated DMV neurones (Zhou
et al. 2001).
Hwang et al. (2001) reported in a recent study that orexin-A
and orexin-B produced postsynaptic depolarization and
increased firing in approximately 30 % of rat DMV
neurones examined at random. They also showed that the
vast majority of DMV neurones that responded with
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Figure 11. Comparative effects of OT and orexin-A in the same DMV neurone
Traces from current-clamp recordings in A and B illustrate the responses of two DMV neurones to sequential
administration of orexin-A (300 nM) and OT (300 nM). A, brief application of either peptide produced
prolonged depolarization and increased spike firing in a fundus-projecting vagal motor neurone. B, by
contrast, a corpus-projecting DMV neurone was excited by orexin-A, but showed no response to












excitation to orexins represented preganglionic para-
sympathetic motor neurones, as determined by their
retrograde labelling following intraperitoneal injection of
Fluorogold (Powley et al. 1987). Our results are consistent
with the observations of these investigators and extend
them in a number of ways. First, we demonstrated that
preganglionic vagal motor neurones respond to orexin
peptides in a viscerotopic manner according to the specific
site of a neurone’s projection in the GI tract. Thus, a large
majority of vagal motor neurones that project to the
gastric fundus or corpus (~70 % of those tested)
responded to orexin-A or orexin-B with depolarization
and increased action potential firing. In contrast,
responsiveness to either form of peptide was observed in a
much smaller percentage of DMV neurones that supplied
the gastric antrum/pylorus (23 %) or duodenum (~19 %)
and rarely encountered in vagal neurones that innervated
the caecum (~8 %). Second, we obtained evidence that
orexin-A evokes depolarization in gastric-projecting vagal
motor neurones primarily by decreasing a resting K+
conductance. In addition, we found that in a subset of these
neurones, orexin-A modulates membrane excitability
indirectly by acting presynaptically to enhance GABA-
mediated synaptic input from the NTS. Lastly, we showed
that orexins and OT produce similar excitatory effects in
many GI-projecting vagal motor neurones, but that
responsiveness to OT is uniformly expressed among DMV
neurones that project to different regions of the GI tract.
Moreover, direct comparison of the effects of orexin and
OT in the same neurone revealed that for the most part
these peptides influence distinct populations of pre-
ganglionic vagal motor neurones. Each of these findings is
considered in greater detail below and their functional
significance discussed.
Responsiveness to orexins is viscerotopically
organized
Results from recent immunohistochemical studies
indicate that the majority of DMV neurones in the rat
express orexin receptors, with the orexin-1 receptors
(OR1) found in greater abundance than orexin-2
receptors (OR2) (Krowicki et al. 2002). In addition,
Krowicki et al. (2002) showed by combining immuno-
staining for OR1 with retrograde labelling of neurones
following injections of fluorescently tagged cholera toxin
into the gastric wall that OR1 is expressed in a majority of
preganglionic vagal motor neurones that innervate the
stomach. The finding in the present study that roughly
70 % of fundus- and corpus-projecting DMV neurones
were excited by orexin peptides is consistent with these
anatomical data. Our results suggest further that relatively
few vagal neurones that supply the gastric antrum/pylorus
express receptors for orexins on their cell bodies. Marcus et
al. (2001) demonstrated using in situ hybridization
histochemistry that OR1 and OR2 have distinct expression
patterns throughout the rat brain, and thus it is
conceivable that these two receptor types may be expressed
differentially in DMV neurones that project to distinct
regions of the GI tract. However, this could not account for
the low incidence of electrophysiological responses to
orexin-A found in antrum/pylorus-projecting DMV
neurones, given that both receptor types have been shown
to exhibit equally high functional affinity for this peptide
(Sakurai et al. 1998; Smart et al. 1999). Currently, we are
examining the effects of microinjection of orexins into the
DMV on regionally specific measurements of gastric
contractility to determine whether the centrally mediated
actions of these peptides evoke changes in gastric motility
and/or tone in proximal, but not distal portions of the
stomach, as predicted by the results from our electro-
physiological experiments.
In contrast to vagal motor neurones that send projections
to the gastric fundus or to the corpus, those that supplied
the small intestine or more distal colon were typically
unresponsive to orexin peptides. This differential pattern
of DMV neurone responsiveness to orexins largely coincides
with the topography of vagal efferent innervation of the rat
GI tract. Thus, the vast majority of preganglionic para-
sympathetic vagal neurones have been shown to heavily
innervate the stomach and most proximal portions of the
duodenum, while providing sparse projections to distal
portions of the intestine and the colon (Berthoud et al.
1991). Similarly, the finding that orexins directly excite a
high percentage of fundus- and corpus-projecting DMV
neurones provides a cellular basis for the stimulation of
gastric acid secretion and contractile activity produced
following intracerebroventicular administration (Takahashi
et al. 1999) and microinjection of orexin-A into the DMV
(Krowicki et al. 2002), respectively. Interestingly, the
pattern of response to orexins exhibited among different
groups of GI-projecting vagal neurones contrasts with the
organizational scheme encountered in the enteric nervous
system, where the distribution of orexin-containing
neurones, nerve fibres and orexin receptors suggests that
the physiological actions of this intrinsic peptidergic
innervation are preferentially concentrated on lower
portions of the GI tract (Kirchgessner & Liu, 1999;
Naslund et al. 2002), Congruent with this, Kirchgessner &
Liu (1999) reported that superfusion of orexin-A
stimulates motility in isolated guinea-pig distal colon. In
addition, it was recently shown in rat that intravenous
infusion of orexin-A or orexin-B inhibits the myoelectric
motor complex in the small intestine, mediated through a
peripheral action of the peptides exerted presumably on
enteric neurotransmission (Naslund et al. 2002). Taken
together, these results provide evidence for a functional
partitioning of the GI effects produced by central release of
orexins from hypothalamic projections into the DMV and
those mediated peripherally by the intrinsic orexin












innervation of the gut. Earlier findings in the rat that
intracisternal administration of orexin-A stimulates
gastric acid secretion via a vagal-dependent mechanism
(Takahashi et al. 1999) suggest that orexin-containing
projections to the DMV may play a key role in cephalic
phase digestive responses to feeding (see Powley, 2000). In
turn, the preferential targeting by central and enteric
orexins of upper and lower digestive tract functions,
respectively, may provide the means for co-ordinating the
cephalic phase of digestion with reflex control of GI
secretions and motor activity that occur upon ingestion
and subsequent digestion of a meal.
Orexins modulate excitability in DMV neurones by
decreasing K+ conductance and enhancing
GABAergic input
The finding that orexin-A and orexin-B depolarized a
majority of gastric-projecting DMV neurones is in keeping
with a number of reports in the literature that demonstrate
direct excitatory effects of these peptides on central
neurones, including those of the arcuate nucleus and
lateral hypothalamus (van den Pol et al. 1998), locus
coeruleus (Horvath et al. 1999a,b; Ivanov & Aston-Jones,
2000), tuberomammillary nucleus (Eriksson et al. 2001),
superficial dorsal horn (Grudt et al. 2002), and dorsal
raphe (Liu et al. 2002). In addition, our results largely
confirm those of Hwang et al. (2001), who first showed
that orexins produce depolarization in rat preganglionic
parasympathetic vagal motor neurones via a postsynaptic
mechanism. These investigators reported that the orexin-
induced depolarizations and underlying inward currents
resulted from the combined activation of a non-selective
cation conductance and a decrease in K+ conductance
(Hwang et al. 2001). We also obtained evidence that
orexin-A and orexin-B increase excitability by means of
this combined action in some DMV neurones. However,
the weight of evidence leads us to conclude that a decrease
in K+ conductance was the predominant, if not sole
mechanism (in some cells) whereby activation of post-
synaptic orexin receptors results in depolarization. Thus,
in virtually all cases the orexin-induced depolarizations
and inward currents were accompanied by an increase in
membrane input resistance. Similarly, in 13 of 17 neurones
examined, the steady-state I–V relationship for the orexin-
induced inward current exhibited a decrease in slope
conductance over the potential range from _120 to
_50 mV and was essentially linear, implying closure of a
non-voltage-gated K+ leak conductance. For these
neurones, the orexin-induced inward current showed a
reversal potential of _104 ± 3.4 mV, which was close to
that predicted for a pure K+ conductance (_107 mV at
34 °C) under our normal recording conditions. Further-
more, the reversal potential for the orexin-induced current
shifted in a Nernstian manner to ~ _60 mV when
neurones were examined in the presence of high-K+ Krebs
solution. The finding that orexin-A did not induce
changes in holding current following intracellular loading
of cells with Cs+ lends additional support to the argument
that a decrease in K+ conductance was largely responsible
for the depolarization observed in a majority of gastric-
projecting DMV neurones. Similar findings have recently
been reported for the depolarizing actions of orexin-B
(hypocretin-2) in NTS neurones (Smith et al. 2002).
Closure of a K+ leak conductance has also been reported to
underlie orexin-induced depolarizations in neurones of
the locus coeruleus (Ivanov & Aston-Jones, 2000) and
dorsal raphe (Brown et al. 2001; but see Liu et al. 2002).
However, this is not the only mechanism by which orexins
act postsynaptically to increase excitability, as exemplified
by the findings in histaminergic tuberomammillary
neurones where these peptides produce depolarization via
activation of both the electrogenic Na+–Ca2+ exchanger
and a Ca2+ current (Eriksson et al. 2001). Although we
found that orexins also promoted Ca2+-dependent spike
discharge in DMV neurones, increased influx of Ca2+ ions
was unlikely to contribute to the depolarizing effects of the
peptides, since the latter responses were not significantly
altered during blockade of Ca2+-dependent events in the
slice with Cd2+.
In addition to having direct excitatory actions,
administration of orexin-A selectively enhanced IPSCs
evoked by NTS stimulation and also unmasked a
bicuculline-sensitive, GABAergic outward current in a
small subset of preganglionic vagal motor neurones.
Interestingly, orexin-A had no effect on orthodromically
evoked EPSCs, and the enhancement in inhibitory
synaptic input was observed in gastric-projecting DMV
neurones that did not show an excitatory response to the
peptide. The orexin-induced enhancement in evoked
IPSCs was accompanied by a significant change in the ratio
of responses elicited by pairs of identical NTS stimuli (i.e.
paired-pulse ratio), indicating that it resulted from actions
of the peptide at a presynaptic site (Trombley &
Westbrook, 1992; Travagli & Williams, 1996). In keeping
with this, administration of orexin-A also increased the
frequency and amplitude of spontaneous IPSCs in a small
fraction of gastric-projecting DMV neurones. However,
we did not find a significant effect of the peptide on
spontaneous mIPSCs, and the bicuculline-sensitive
outward currents that were unmasked by orexin-A were
abolished during blockade of impulse-dependent release
with TTX. Taken together, these data suggest that
orexin-A may act indirectly to facilitate GABA-mediated
synaptic input onto a subpopulation of gastric-projecting
DMV neurones, largely by increasing the activity of NTS
neurones (but see Smith et al . 2002). Furthermore, orexins
(hypocretin-2) have recently been shown to have
excitatory effects on a large percentage of neurones in
caudal NTS (Smith et al. 2002).












Although the functional significance of this selective
facilitation of synaptic inhibition is unclear, it may relate
to the finding in vivo that microinjection of orexins into
the caudal portion of the DMV evokes gastric contraction,
rather than relaxation as occurs upon glutamatergic
activation of neurones in this part of the nucleus (Krowicki
et al. 2002). It should be noted in this regard that pre-
ganglionic neurones in the rostral DMV mainly synapse
on to excitatory intragastric motor neurones, whereas
many of those located in the caudal DMV project onto
inhibitory non-adrenergic, non-cholinergic postganglionic
neurones that evoke gastric relaxation (Rossiter et al. 1990;
Takahashi & Owyang, 1997; Zheng et al. 1999).
Nevertheless, it remains to be seen whether the facilitating
effects of orexins on synaptic inhibition from NTS are
differentially expressed among distinct groups of vagal
motor neurones according to their specific functionality
and/or their anatomical location within the DMV.
Interestingly, the actions of orexins on information
processing within the DMV recapitulate a pattern that
occurs in the spinal cord dorsal horn (Grudt et al. 2002)
and the dorsal raphe, where orexin-A and orexin-B
modulate the activity of target neurones by producing
postsynaptic excitation and also by selectively increasing
inhibitory synaptic input. By contrast, orexins have been
reported to inhibit synaptic transmission in the enteric
nervous system, reducing the amplitude of excitatory and
inhibitory postsynaptic potentials evoked in submucous
plexus neurones following stimulation of interganglionic
nerve bundles (Kirchgessner & Liu, 1999).
Orexins and OT excite distinct populations of vagal
neurones
OT produced a slow depolarization and increased firing in a
large percentage (45 %) of GI-projecting DMV neurones,
confirming earlier in vivo results and findings in brainstem
slice preparations that OT has direct stimulatory effects on
preganglionic vagal motor neurones in rat (McCann &
Rogers, 1990; Dubois-Dauphin et al. 1992; Raggenbass &
Dreifuss, 1992). Dubois-Dauphin et al. (1992) reported
that OT induced depolarization and/or generated an
inward current in 78 % of a heterogeneous population of
vagal motor neurones, identified in brain slice recordings
by antidromic invasion following stimulation of vagal nerve
fibres. We found that responsiveness to OT was expressed to
a more limited extent in DMV neurones that were
unambiguously defined as projecting to specific sites in the
GI tract based on their retrograde labelling with DiI. This
discrepancy in results could be explained if excitatory OT
receptors are highly expressed in vagal neurones that
supply the thoracic viscera, and many of these neurones
were included in the study by Dubois-Dauphin et al.
(1992). On the other hand, McCann & Rogers (1990)
found by recording extracellularly in vivo in the DVC that
iontophoretic administration of OT excited the vast
majority (~85 %) of vagal motor neurones identified as
having a gastric-related function. It could not be
determined from their study to what extent the increases
in cellular discharge produced by OT resulted from direct
effects on the gastric-related vagal neurones themselves, or
were mediated indirectly via presynaptic actions of the
peptide. In this regard, OT was also found to excite
virtually all (90 %) NTS neurones examined that were
identified as being gastric-related (McCann & Rogers,
1990). Our results indicate that roughly half of the
preganglionic vagal motor neurones that innervate the
stomach express functional OT receptors and respond
with postsynaptic excitation upon binding of the peptide.
However, only a fraction (approximately 35%) of gastric-
projecting DMV neurones that are excited by OT appear to
also be responsive to the excitatory effects of orexin
peptides and vice versa. Increasing the extracellular level of
OT or orexin-A within the DMV, either through direct
administration of peptide into the brain or via stimulation
of corresponding peptide-containing inputs into the
nucleus, has been shown to stimulate gastric acid secretion
in rats via a vagal-dependent mechanism (Rogers &
Hermann, 1985, 1987; Takahashi et al. 1999). Accordingly,
it seems reasonable to posit that the gastric-projecting
DMV neurones identified here that were excited by both
orexins and OT are involved in the control of gastric acid
secretion. Conversely, microinjection of orexin peptides
into the DMV has been reported to stimulate gastric
contraction (Krowicki et al. 2002), whereas direct
administration of OT into the nucleus or activation of OT-
containing synaptic inputs from the PVN inhibits gastric
contractility and reduces basal tone (Rogers & Hermann,
1987; Flanagan et al. 1992). A plausible explanation for
this, suggested by the present data, is that orexin- and OT-
containing input to the DMV may excite functionally
distinct groups of vagal motor neurones that in turn evoke
gastric contraction and relaxation, respectively, through
activation of cholinergic excitatory and non adrenergic,
non-cholinergic inhibitory postganglionic intragastric
neurones. Furthermore, blockade of central OT receptors
has been reported to increase baseline gastric motility in
adult rats (Flanagan et al. 1992), suggesting that
endogenous OT may exert tonic inhibitory control over
specific components of vagal efferent outflow and thus
counterbalance the gastro-stimulatory effects mediated by
orexin-containing input from the LH. The present results
provide a cellular basis for the differential control of gastric
motor function by descending orexin-containing and
oxytocinergic hypothalamic projections to the DMV.
Nevertheless, it remains to be determined how and to what
extent these effects participate in the co-ordination of
feeding behaviour and energy balance that is achieved in
large part via the neuronal circuitry and projection systems
of the LH and hypothalamic PVN.
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